Background A family history (FH) of prostate cancer (PrCa) is associated with an increased
likelihood of PrCa diagnosis. Conflicting evidence exists regarding familial PrCa and clinical …

Genetic factors may be used not only to assess risk of prostate cancer development but also
to evaluate prostate cancer outcomes including clinical prognosis, treatment methods, and …

Objective To estimate the survival of men with familial prostate cancer and compare them
with prostate cancer cases unselected for family history. Patients and methods The overall …

Abstract Learning Objectives After completing this course, the reader will be able to: Assess
the relationship between the cumulative prostate cancer–specific mortality rate and the …

Purpose To report on the aggressiveness of sporadic versus familial prostate cancer.
Patients and Methods The study sample consisted of 4,112 stage T1-3 prostate cancer …

Background To investigate the correlation between family history of prostate cancer (PCa)
and survival (overall and cancer specific) in patients undergoing treatment for PCa. Methods …

Objectives To compare traditional prognostic characteristics of familial vs sporadic prostate
cancers and to investigate potential detection biases arising from differences in the use of …

Abstract Objectives The Swedish Family-Cancer Database has been the major source of
population-based prospective data on familial risks on most cancers, including prostate …

BACKGROUND: The thorough assessment of familial prostate cancer (PCa) risk is as
important as ever to provide a basis for clinical counselling and screening …

Objective: We evaluated if epidemiological features of familial prostate cancer are
associated with certain clinical or histopathological characteristics of the disease. Methods …